Diego Miralles
Net worth: 614 575 $ as of 31/05/2026
Net worth: 614 575 $ as of 31/05/2026
Dr. Diego Miralles, MD, is a President & Head-Research & Development at Artiva Biotherapeutics, Inc., an Adjunct Professor at University of California San Diego and a Venture Partner at CHP Management, Inc. He is on the Board of Directors at Contineum Therapeutics, Inc., S.V.D.P.
Management, Inc., Artiva Biotherapeutics, Inc., Rady Children's Institute for Genomic Medicine and ArrePath, Inc. Dr. Miralles was previously employed as an Advisor by Flagship Pioneering, Inc., a President, Chief Executive Officer & Director by Laronde, Inc., a Chief Executive Officer & Director by Vividion Therapeutics, Inc., a President by Adaptive Therapeutics, Inc., a Senior Director by Trimeris, Inc., a Medical Director by Triangle Pharmaceuticals, Inc., an Assistant Professor by Duke University Medical Center, and a Member-Management Board by Tibotec Virco Virology BV.
He also served on the board at Neubase Therapeutics, Inc. /Old/, NeuBase Therapeutics, Inc. and CONNECT.
He received his doctorate degree from Universidad de Buenos Aires.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/05/2026 | 77,500 ( 0.16% ) | 614 575 $ | 31/05/2026 | |
| 26/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Director/Board Member | 14/03/2025 |
| ARTIVA BIOTHERAPEUTICS, INC. | President | 18/05/2026 |
S.V.D.P. Management, Inc.
S.V.D.P. Management, Inc. Miscellaneous Commercial ServicesCommercial Services Provides one-stop shopping services | Director/Board Member | 01/03/2025 |
Rady Children's Institute for Genomic Medicine | Director/Board Member | 01/01/2008 |
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance Cardinal Partners invests in companies located in the United States. The firm focuses on life sciences, virtual care, machine learning/NLP/blockchain, disruptive healthcare technology and consumer sectors. It provides financing for early, growth and recapitalization transactions with an investment size of USD 6 - 12 million. | Private Equity Investor | - |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ArrePath, Inc.
ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Chief Executive Officer | 01/09/2022 |
Laronde Inc.
Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Chief Executive Officer | 30/09/2022 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 19 |
|---|---|
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antiviral drug candidates | Commercial Services |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance Cardinal Partners invests in companies located in the United States. The firm focuses on life sciences, virtual care, machine learning/NLP/blockchain, disruptive healthcare technology and consumer sectors. It provides financing for early, growth and recapitalization transactions with an investment size of USD 6 - 12 million. | Finance |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Therapeutics, Inc.
Adaptive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Universidad de Buenos Aires
Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
S.V.D.P. Management, Inc.
S.V.D.P. Management, Inc. Miscellaneous Commercial ServicesCommercial Services Provides one-stop shopping services | Commercial Services |
Duke University Medical Center
Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Commercial Services |
Tibotec Virco Virology BV | |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Neubase Therapeutics, Inc. /Old/
Neubase Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops peptide-nucleic acid antisense oligonucleotide platform | Health Technology |
Rady Children's Institute for Genomic Medicine | |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Laronde Inc.
Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Commercial Services |
ArrePath, Inc.
ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery | Health Technology |
Select your edition
All financial news and data tailored to specific country editions